Tag: sirolimus-eluting balloon
PCR e-Course 2020: Sirolimus-eluting balloon is a valid treatment for vasculogenic...
A sirolimus-eluting balloon has been shown to be effective and safe for the treatment of vasculogenic erectile dysfunction (ED) in a first-in-man study presented...
First patient enrolled globally in SELUTION SLR study for AV fistulae
MedAlliance has announced enrolment of the first patient in the SAVE (Use of the Selution sirolimus-eluting balloon for dysfunctional AV access treatment indications) study...
Patient enrolment completed in MedAlliance PRESTIGE BTK clinical trial
MedAlliance has announced completion of patient enrolment in the PRESTIGE below-the-knee (BTK) clinical trial. The objective of this clinical investigation is to evaluate the...
Orchestra BioMed announce FDA breakthrough device designation for Virtue sirolimus-eluting balloon
Orchestra BioMed, in partnership with Terumo Corporation, today announced that the company has secured breakthrough device designation by the US Food and Drug Administration...
Virtue sirolimus-eluting balloon set for commercial release as Terumo and Orchestra...
Orchestra BioMed and Terumo have formed a global strategic partnership for the development and commercialisation of Virtue sirolimus-eluting balloon (SEB) in the percutaneous coronary...
